Grifols

GRFS

0 Obserwujący

$7.24

-0.75%

-$0.06

Obserwuj

12 Maj

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

GRFS Fair Price

$4.14

Undervalued by 36.2%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Grifols, S.A. is a global Spanish pharmaceutical and biotechnology company specializing in the production of plasma-derived medicines and healthcare products. The company focuses on producing immunoglobulins, albumin, and other plasma-based products that are essential for the treatment of various diseases, including immunological and neurological disorders. Grifols also develops diagnostic tools and systems for hospitals and clinics. The company has a broad global presence and operates in over 30 countries worldwide.

Feed

There are no posts to show right now.